Ampersand Capital Partners’s acquisition of majority interest in Corpus Medical, Inc.

Corpus Medical, Inc., a Silicon Valley-based contract development and manufacturing organization focused on interventional medical devices, catheter-based delivery systems and implants, announced that it has completed a majority recapitalization with Ampersand Capital Partners.

Ampersand’s investment will be used to further expand the Company’s manufacturing capabilities and geographic footprint.

The Company was founded by the senior management team in 2009 to provide value-added contract development and manufacturing services, with the mission of assisting customers to get their products to market more efficiently. Corpus will continue to operate from its Campbell, CA headquarters, where it has made meaningful recent investment in cleanroom manufacturing capacity, and the current management team will continue to lead the Company.

Ampersand is a middle market private equity firm with a focus on growth equity investments in the healthcare sector. Over the past two decades, Ampersand has managed more than $1 billion in private equity partnerships. Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams.

Jones Day advised Corpus Medical, Inc. in its majority acquisition by Ampersand Capital Partners with a team led by M&A partners Khoa Do (picture) and Micheal Reagan.

Involved fees earner: Khoa Do – Jones Day; Micheal Reagan – Jones Day;

Law Firms: Jones Day;

Clients: Corpus Medical, Inc.;


Author: Ambrogio Visconti